A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.

Derbel, Olfa; Cannas, Giovanna; Le, Quoc-Hung; Elhamri, Mohamed; Chelghoum, Youcef; Nicolas-Virelizier, Emmanuelle; Nicolini, Franck; Troncy, Jacques; Barraco, Fiorenza; Michallet, Mauricette; Thomas, Xavier

Derbel, Olfa; Cannas, Giovanna; Le, Quoc-Hung; Elhamri, Mohamed; Chelghoum, Youcef; Nicolas-Virelizier, Emmanuelle; Nicolini, Franck; Troncy, Jacques; Barraco, Fiorenza; Michallet, Mauricette; Thomas, Xavier.

Affiliation

Derbel O; Service d'Hématologie, Hôpital Edouard Herriot, Lyon, France.

Hematology ; 15(3): 125-31, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20557669

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/adverse effects; Granulocyte Colony-Stimulating Factor/administration & dosage; Leukemia, Myeloid, Acute/blood; Leukemia, Myeloid, Acute/drug therapy; Neutropenia/drug therapy; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cytarabine/administration & dosage; Cytarabine/adverse effects; Drug Administration Schedule; Etoposide/administration & dosage; Etoposide/adverse effects; Female; Filgrastim; Humans; Male; Middle Aged; Mitoxantrone/administration & dosage; Mitoxantrone/adverse effects; Neutropenia/chemically induced; Polyethylene Glycols; Prognosis; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Granulocyte Colony-Stimulating Factor / Neutropenia Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Hematology Journal subject: HEMATOLOGIA Year: 2010 Type: Article Affiliation country: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google